Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News

Coronavirus Omicron Subvariant BA.5 Surging in China May Be Evolving to Attack the Brain, Researchers Say

By Charles Gross
Today, 11:23 PM
-South China Morning Post https://www.scmp.com/news/china/science/article/3204807/coronavirus-omicron-ba5-subvariant-may-cause-more-damage-not-less-study?module=live&pgtype=homepage

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Global
  • News

BioNTech And Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination Of German Expatriates In China

By Benzinga Newsdesk
Today, 11:23 PM
Approximately 11,500 of the companies' mRNA-based COVID-19 vaccine doses arrived on the Chinese Mainland to enable vaccination campaign for German expatriates Vaccines expected to be available in

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

BioNTech Starts Dosing In Herpes Vaccine Candidate Study

By Vandana Singh
Today, 11:23 PM
BioNTech SE (NASDAQ:BNTX) has dosed in a first-in-human Phase 1 clinical research study with BNT163, a herpes simplex virus…

BNTX

Read More
1 minute read
  • Global
  • News

World Health Organization’s Ryan Says He Would Encourage Work To Import COVID mRNA Vaccines To China

By Benzinga Newsdesk
Today, 11:23 PM
- Reuters

AZN

Read More
1 minute read
  • Global
  • News

German Government Spokesperson Says Can Confirm A Shipment Of BioNTech Vaccine Is On Its Way To China

By Bill Haddad
Today, 11:23 PM
-Reuters

BNTX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Upgrades

BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities

By Vandana Singh
Today, 11:23 PM
BofA Securities has upgraded BioNTech SE (NASDAQ:BNTX) and maintains a $239 price target. The analyst views the current valuation as an attractive…

BNTX

Read More
2 minute read
  • Biotech
  • General
  • Legal
  • News

‘Florida Gov. DeSantis Calls For Grand Jury To Investigate Covid Vaccines’ – InsiderPaper

By Benzinga Newsdesk
Today, 11:23 PM
https://insiderpaper.com/florida-gov-desantis-calls-for-grand-jury-to-investigate-covid-vaccines/ Ron DeSantis, the Governor of Florida, announced his decision to appoint a grand jury to investigate the

AZN

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Pfizer Expects $10-$15B From mRNA Vaccine Sales By 2030, Sees $17B Revenues Lost Due To Patent Expiry

By Vandana Singh
Today, 11:23 PM
At Pipeline Day, Pfizer Inc (NYSE: PFE) forecasts annual revenue from its mRNA vaccine portfolio could reach $10-$15 billion by 2030.

BNTX

Read More
1 minute read
  • Global
  • News

China’s Ambassador To The United States Qin Gang Says He Believes China’s COVID-19 Measures Will Be Further Relaxed In Near Future And International Travel To China Will Become Easier

By Benzinga Newsdesk
Today, 11:23 PM
- Reuters

AAL

Read More
1 minute read
  • Biotech
  • General
  • News

EMA: Healthcare Professionals Advised To Check Current Covid-19 Situation And Consider Alternative Antiviral Treatments Like Paxlovid, Remdesivir

By Benzinga Newsdesk
Today, 11:23 PM
- Reuters

AZN

Posts navigation

Previous 1 … 3 4 5 … 92 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service